Upload
vukiet
View
219
Download
0
Embed Size (px)
Citation preview
ICP Version 1 June 2010: Review May 2011 Page 1 of 14
Care Pathway
The information contained in this integrated care pathway is confidential and it is the responsibility of all members of staff to ensure that it remains so. The information
contained within should only be accessed on a strict „need-to-know‟ basis.
All Wales Care Pathway for the Last Days of Life (Based on the Liverpool Royal United Hospitals’ ICP for the dying patient*) Incorporating Changing Gear**
The Care Pathway is intended as a guide in providing care for the patient and their family in the last days of life.
As a multi-disciplinary document it replaces the current medical and nursing notes during this period of care. These guidelines are based on best accepted practice. Each professional should exercise their professional judgment when using this guidance. INSTRUCTIONS FOR USE 1. Medical & Nursing Assessments should be completed while the patient care is guided by
the Pathway. 2. When care pathway is being used all risk assessments together with pressure area and
personal care continue as before 3. Ongoing Assessment (nursing) should be completed every 4 hours or at each visit using
a new sheet each day. 4. Variance occurs if the Pathway is not followed as expected. Any variance should be
recorded on the variance sheet, If a box in italics is ticked, explain action/inaction on variance sheet. N.B. A variance is not wrong, but it is important to record it, to help with quality monitoring and audit.
5. Multi-disciplinary progress notes allow scope to record anything not covered by the Pathway. These should record communication with the patient and family.
* LCP Ellershaw J., Foster A., Murphy D., et al. (1997). Developing an Integrated Care Pathway For Dying Patients. ‘European Journal of Palliative Care’ 4 page 203-207. ** Changing Gear updated November 2006 www.ncpc.org.uk
Contact Details
ICP Version 1 June 2010: Review May 2011 Page 2 of 14
Medical Assessment
DIAGNOSIS
Criteria for ICP Do Not use the care pathway for the last days of life unless these two are fulfilled
1 Have reversible causes of deterioration been excluded? Yes No
2 Does the team agree that the patient is dying Yes No
GP/Consultant If an in-patient has GP been informed of situation? Yes No
Would the patient / family like to talk to somebody about tissue/organ donation ? Yes No
If yes phone: North Wales 0800 4320559
South Wales 07659 591889
GOAL 1 PLACE OF CARE
Is the patient in his / her currently preferred place of care Yes No Don’t Know
GOAL 2 CURRENT MEDICATION ASSESSED AND NON ESSENTIALS DISCONTINUED
Appropriate oral drugs converted to subcutaneous route via syringe driver
(if required) Yes No
GOAL 3 HYDRATION
In some patients or following discussion with relatives it may be appropriate to use s/c fluids
Parenteral fluids required Yes No
GOAL 4 PRN WRITTEN UP (AS LIST BELOW) – REFER TO GUIDELINES
Pain - Diamorphine Yes No
N&V - Cyclizine Yes No
Agitation - Midazolam Yes No
Respiratory Tract Secretions - Hyoscine Hydrobromide Yes No
GOAL 5 DISCONTINUE INAPPROPRIATE INTERVENTIONS
Blood Tests Yes No Not applicable
Treatments that are failing to achieve therapeutic goal Yes No
Implantable Cardiac Defibrillator deactivated Yes No Not applicable
DNACPR written in Medical notes/form completed Yes No
DNACPR discussed with relatives Yes No Not applicable
Doctor’s Signature __________________________ Date ______________________
Print Name ______________________________________
Name: Date of Birth: Address: NHS Number:
Date………………………
Yellow
ICP Version 1 June 2010: Review May 2011 Page 3 of 14
Nursing Assessment
GOAL 6 COMFORT MEASURES
(Consider the environment: comfort, safety, temperature, ventilation).
Recording of Blood Pressure discontinued Yes No
Pressure areas assessed Yes No
Assessed need for - special mattress Yes No
- single room Yes No Not Applicable
Assessed condition of mouth Yes No
Action taken on any of above assessments:
GOAL 7 COMMUNICATION
Preferred language: Barriers to communication:
GOAL 8 IDENTIFY AND ADDRESS PATIENT‟S FEARS AND ANXIETIES
Patient recognises that they are dying Yes No Don’t Know Fears identified (specify):
GOAL 9 MOBILITY/SAFETY
Supervision required Yes No
Assessed for bed aids / sliding sheet. Yes No
GOAL 10 MICTURITION DIFFICULTIES
Urinary catheter if in retention. Yes No
Urinary catheter or pads, if general weakness creates incontinence
GOAL 11 HAZARDS IDENTIFIED
Infection/ radiation control referral if appropriate Yes No Not Applicable
GOAL 12 SPIRITUAL/RELIGIOUS/CULTURAL REQUIREMENTS
Religion identified (please specify): …………………………………………………………….. If appropriate – contact made with relevant minister? Yes No Contact name: Tel. no: Religious/cultural needs identified & action taken: Yes No Not Applicable
Name: Date of Birth: Address: NHS Number:
Green
Date………………………
ICP Version 1 June 2010: Review May 2011 Page 4 of 14
GOAL 13 BEREAVEMENT PLANNING/FAMILY CARE
Family recognise that patient is dying Yes No Don’t Know
Care discussed with relative
and recorded on MDT sheet Yes No
Anxieties or Fears identified, please state:
GOAL 14 DETAILS OF HOW TO INFORM FAMILY/ OTHERS OF IMPENDING DEATH
At anytime Not at night Contact name: Relationship to patient: Telephone No: Second contact name and number:
GOAL 15 FAMILY GIVEN LOCAL INFORMATION
Family shown local facilities Yes No - over-night stay, availability of food and drinks, location of phones, washing facilities, parking arrangements etc. Family needs (please state): ……………………………………………………………
Nurse’s signature ___________________________ Date _______________ Print Name _______________________________________________
Green
Name: Date of Birth: Address: NHS Number:
Date………………………
ICP Version 1 June 2010: Review May 2011 Page 5 of 14
Regular Symptom Assessment & Review CODES (to enter in columns) A – goal achieved, V – goal not achieved record on variance sheet, N/A – not applicable
DATE & TIME
PATIENT IS FREE OF:
GOAL 16 PAIN
GOAL 17 AGITATION
GOAL 18 “RATTLING” SECRETIONS
GOAL 19 NAUSEA / VOMITING
GOAL 20 MOUTH CARE
Mouth care carried out & mouth is clean
GOAL 21 MEDICATION
Medications reviewed & delivered safely.
GOAL 22 INTERVENTIONS
Inappropriate interventions discontinued
GOAL 23 COMMUNICATION – PATIENT
Patient aware of situation as appropriate.
GOAL 24 COMMUNICATION – FAMILY/ OTHERS
Family/others prepared for patient‟s death.
GOAL 25 OTHER SYMPTOMS
Other distressing symptoms controlled
Symptom Goal Symptom Goal
Print Name & sign each observation
Name: Date of Birth: Address: NHS Number:
Date………………………
Blue
ICP Version 1 June 2010: Review May 2011 Page 6 of 14
CARE AFTER DEATH
CARE AFTER DEATH
Death Verification
Date of death ____________________________ Time of death ______________ Signature of verifier _____________________ Date __________ Time ________ Print Name _____________________
Death Certification
Date of death ____________________________ Time of death ______________ Signature of certifier _____________________ Date __________ Time ________ Print Name _____________________
GOAL 26 FAMILY To prepare, inform and support the patient‟s family /others, during final stages and immediately after death
Coroner needs to be informed Yes No
Post mortem discussed Yes No
Mortuary viewing explained Yes No
Collection of belongings / valuables explained Yes No
Collection of certificate explained Yes No
Please tick one option
Patient for burial
Patient for cremation for cremation see below
Names of people present at time of death and relationship to the deceased:
GP informed of death by telephone or fax Yes No Date __/__/__ Time ___________ Health Professional Signature _______________________ Date _______________
Print Name ____________________________
Name: Date of Birth: Address: NHS Number:
Date………………………
ICP Version 1 June 2010: Review May 2011 Page 7 of 14
Multi-disciplinary Progress Notes/Communication Sheet
Date Signature
Name: Date of Birth: Address: NHS Number:
Date………………………
ICP Version 1 June 2010: Review May 2011 Page 8 of 14
Variance Page Gender………….. Age ……….. Diagnosis …………………………. No of Days on Pathway…………
Date Variance and explanation Action Taken Outcome Signature
Please state you locality ………………..
Please indicate setting: Community Hospital District Nurses Hospice Nursing Home DGH SPU Other / state…………………
Please return a photocopy of variance page/s to:- Ros Johnstone Project Manager at the Palliative Care Department Bodfan Eryri Hospital Caernarfon LL55 2YE
Name: Date of Birth: Address: NHS Number:
Date………………………
ICP Version 1 June 2010: Review May 2011 Page 9 of 14
PRN Medication
Symptom Medication Dose Frequency Route Doctor‟s Signature
Date
Nausea/ Vomiting
Cyclizine Max 150mg/24hrs BNF
50mg 4hrly sc
Agitation Midazolam Max 30mg/24hrs BNF
5-10mg 2hrly sc
“Rattle” Hyoscine Hydrobromide Max 2.4mg/24hrs BNF
0.6mg 4hrly sc
Pain
See Guidelines
Others
PRN MEDICATION GIVEN
Date Time
Drug Dose Route Signature (Given by)
Signature (Checked by)
Name: Date of Birth: Address: NHS Number:
Date………………………
ICP Version 1 June 2010: Review May 2011 Page 10 of 14
Guidelines for symptom management (Reference Dr I.N.Back Palliative Medicine Handbook http://book.pallcare.info
Syringe Drivers
Syringe drivers are not always necessary, but are extremely useful if the patient is: • nauseous or vomiting, or has poor oral absorption • unable to swallow or too weak for oral drugs • unconscious All the drugs in the guidelines are compatible in mixtures in a syringe driver. • Precipitation may occur with higher concentrations of cyclizine. • Water for injection to be used to dilute all drugs except levomepromazine (use 0.9% saline)
If the patient has renal impairment but is tolerating conventional analgesics use them, but consider dose
reduction. However if there are signs of opiate toxicity seek specialist palliative care or pharmacy advice.
Pain
Is the patient able to swallow medication? If yes: continue oral morphine SR + 1/6th dose for breakthrough pain If no: convert to a syringe driver with diamorphine (if converting to injected morphine, see section in italics below.) Use EITHER diamorphine or morphine as the parenteral drug. If converting to syringe driver with DIAMORPHINE: • Calculate 24h intake of morphine. • Divide total by 3 to get the equivalent dose of diamorphine CSCI over 24h. e.g. Patient on 60mg MST b.d. and had 3 doses of 20mg Oramorph
Total (60 x 2) + (3 x 20) =180mg morphine total in 24h Equivalent dose of diamorphine = 180/3 = 60mg/24h • Also needs breakthrough dose prescribing of 1/6th of syringe driver i.e. 10mg diamorphine 4-hourly SC PRN). If converting to syringe driver with MORPHINE: • Calculate 24h intake of morphine. • Divide total by 2 to get the equivalent dose of morphine CSCI over 24h. e.g. Patient on 60mg MST b.d. and had 3 doses of 20mg Ooramorph Total (60 x 2) + (3 x 20) =180mg morphine total in 24h Equivalent dose of morphine = 180/2 = 90mg/24h • Also needs breakthrough dose prescribing of 1/6th of syringe driver i.e. 15mg morphine 4-hourly SC PRN). If not previously on a strong opioid: • Bolus diamorphine or morphine 2.5-5mg SC • Syringe driver 10-20mg diamorphine or morphine CSCI over 24h • PRN medication - 2.5-5mg SC diamorphine or morphine 4-hourly To calculate subsequent dose of diamorphine or morphine: • Add the dose of diamorphine or morphine (i.e. syringe driver) plus all PRN doses given in the previous 24hrs. • Increase the syringe driver dosage accordingly. If pain persists, consider other causes of distress e.g. bone pain, neuropathic pain, anxiety, fear, full bladder. If
pain is not controlled, contact the local Palliative Care Team.
ICP Version 1 June 2010: Review May 2011 Page 11 of 14
Fentanyl / Syringe Driver Always leave patch in situ when commencing a syringe driver
Fentanyl or buprenorphine transdermal patches can continue to be used in the last few days of life. However, it is not appropriate to alter the dose of the patches for any change in analgesic requirement, as there is a delay before the changes are clinically apparent.
Patient who is pain controlled Continue current medication i.e. fentanyl or buprenorphine patch, refreshing the patch every 72h (or as previously
managed). Use diamorphine sc for breakthrough pain.
Patient not pain controlled: Continue patch at its current dose. Add diamorphine CSCI via syringe driver. The dose in the syringe driver is calculated on previous 24h PRN
requirement converted to diamorphine equivalence e.g. patient on 75µg/h fentanyl patch who has required 2 doses of PRN oral morphine 45mg in the last 24h = 90mg oral morphine /24h.
diamorphine 30mg/24h CSCI Breakthrough doses should be 1/6
th of total 24h opioid use i.e. diamorphine + equivalence of patch e.g.
patient on 75µg/h fentanyl and 30mg/24h diamorphine CSCI patch equivalence (90mg/24h diamorphine) + diamorphine 30mg/24h CSCI : divided by 6 diamorphine 20mg sc breakthrough. Further increments in syringe driver dose should also take the patch equivalence into consideration e.g. if a patient on 75µg/h fentanyl patch and 30mg/24h diamorphine CSCI requires an increase in syringe driver dose Total equivalent diamorphine dose = 120mg/24h (as above) Increment of 25% = an additional 30mg/24h daimorphine New syringe driver dose = 30 + 30 = 60mg/24h diamorphine CSCI (and continue fentanyl patch 75µg/h) Further details available in Trust Formulary and BNF pages 12-15
Nausea and Vomiting • PRN medication on all treatment sheets: cyclizine 50mg SC bolus 4hrly • If nauseous or vomiting: cyclizine 150mg SC via syringe driver over 24h If patient has congestive heart failure use haloperidol rather than cyclizine • If problem persists: Add haloperidol 5mg to syringe driver over 24h, or Replace above drugs with levomepromazine 12.5mg over 24h Contact Palliative Care Team • If bowel obstruction present: contact Palliative Care Team.
Restlessness, Agitation, Anxiety
• All treatment sheets to have PRN midazolam 5-10mg SC • If patient is restless: Add 10mg midazolam to syringe driver over 24h Give up to 5mg midazolam 2-hourly PRN • The dosage in the syringe driver can be increased if needed in 50% increments to a maximum of 30mg in 24 hours. If patient remains restless, review for reversible causes, contact Palliative Care Team.
Noisy Breathing due to Respiratory Tract Secretions
• All treatment sheets to have hyoscine hydrobromide 0.4-0.6mg SC 4-hourly written up. • If symptom present give: hyoscine hydrobromide 0.4mg SC bolus Add hyoscine hydrobromide 1.2mg SC to syringe driver over 24h. • If symptoms persist: Increase hyoscine hydrobromide to 2.4mg (in 24h). Contact Specialist Palliative Care Team.
Out of Hours Specialist Telephone Help Line:
North Wales: 01978 316800
South East Wales: 02920 426000 South West Wales
ICP Version 1 June 2010: Review May 2011 Page 12 of 14
ICP Version 1 June 2010: Review May 2011 Page 13 of 14
OUT OF HOURS COMMUNICATION SHEET
Integrated Care Pathway For The Last Days Of Life
URGENT FOR IMMEDIATE ATTENTION OF DOCTOR
When ICP commenced, please complete and fax this sheet to relevant Out of Hours Service
FROM: SIGNATURE:
DESIGNATION: DATE AND TIME:
OOH Fax
Numbers
Central – 01745 534220 East – 01244 834971 West – 01248 370138
PATIENT DETAILS
Name:
D.O.B
Address:
Telephone No:
Next of Kin/Main Carer: Address: Telephone No:
PATIENT‟S OWN GP DETAILS
Name: Practice Name: Telephone No:
Date of Notification to Out of Hours Service: Do you wish to be contacted concerning care?
Yes No
OTHER SERVICES INVOLVED: - Please indicate
District Nurses: Marie Curie Nursing Service: Macmillan Specialist Palliative Care Team:
DIAGNOSIS AND RELEVANT HISTORY
Patient aware of Diagnosis Relatives aware of Diagnosis
Yes No Yes No
DRUGS PRESCRIBED FOR THIS PATIENT - Please Indicate
Diamorphine YES/NO
Hyoscine YES/NO
Midazolam YES/NO
Cyclizine YES/NO
Water for injection YES/NO
MANAGEMENT PLAN
ICP Version 1 June 2010: Review May 2011 Page 14 of 14
LABEL
All-Wales DNACPR Form – COMMUNITY ADULT ONLY (over 18 years)
FO
RM
DN
A-C
PR-C
OM
M-v
1 J
ul 2009
Full name of patient …………………………………………………………………………………………………………………………………………………………
Patient NHS/Hospital No …………………………………………………………. Date of Birth …………………………………………………………
Address ………………………………………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………. Postcode ……………………………………………………………….
A decision has been taken that Cardio-Pulmonary Resuscitation (CPR) is NOT appropriate for the above patient. All other appropriate treatment and care should be provided.
Any discussion around this decision (with patients, relatives, team members etc) should be clearly documented in patient’s notes.
Please tick ONE of the 3 boxes below. The patient is being cared for with the Last Days of Life care pathway
1 and CPR is inappropriate.
CPR has been discussed with the patient/next of kin/proxy2
The patient/next of kin/proxy is aware that the patient is imminently dying from an irreversible disease, and discussion of CPR is not considered appropriate
CPR is unlikely to be successful or is likely to be followed by a length and quality of life which would not be in the best interests of the patient.3
This has been discussed and agreed with the patient's next of kin/proxy2
The patient lacks capacity to make this decision due to an irreversible condition4
All reasonable attempts have been made to exclude communication barriers to discussion with the patient
The decision is not contrary to any known advance decision of the patient
CPR is not in accord with the known or expressed sustained wishes of the patient.5
This has been discussed with the patient, who is mentally competent
This has been documented in a valid applicable advance decision to refuse treatment, which I have read6
Where is the advance decision document kept? ……………………………………………………………………………………………………
If discussion has taken place with family or proxy, please tick and give details:
Name of relative or proxy DELETE AS APPROPRIATE Next of kin / LPA / CAD / IMCA2
Contact details
Signature of senior Health Care Professional
Date:
Print full name Time:
Address Tel No:
DO NOT ATTEMPT CPR RESUSCITATION (DNACPR)
1 CARE PATHWAY
2 BEST-INTERESTS DECISION
3 ADVANCE DECISION BY PATIENT
Review of DNACPR Status
DNACPR status should be reviewed when there is any significant change in the patient's circumstances.
If the DNACPR decision is cancelled, please:
strike through both sides of this form
file this form in the patient's health record
inform other care providers
Notes 1 The Last Days of Life care pathway is also known as the All-Wales Integrated Care Pathway for the Dying, and other
similar names. Discussion with the patient/next of kin/LPA/CAD/IMCA is not compulsory in this situation, but one of the options must be ticked.
2 Proxy means one of the following: LPA = Lasting Power of Attorney; IMCA = Independent Medical Capacity Advocate; CAD = Court Appointed Deputy. Delete as appropriate.
3 A best-interest decision made on behalf of a patient must meet all the conditions of the Mental Capacity Act 2005. In a ‘best-interest’ decision, all 4 of the boxes must be ticked. You should also record details of discussions in the patient’s notes.
4 Please refer to the Mental Capacity Act 2005 for conditions when determining a 'best-interest' decision for a patient who lacks capacity.
5 Discussion with the next of kin is not compulsory in this situation, but is strongly advised (with the patient’s permission). One of the 2 options must be ticked.
6 Please refer to the Mental Capacity Act 2005 for details of what constitutes a "valid applicable advance decision".
COMMUNITY NURSING SERVICE (for use in the patient’s home)
Controlled & Other Prescribed Drugs for use in Syringe Drivers
Date Drug Dose Freq Route Doctor’s Signature Disc
Date
Name:
Date of Birth:
Address:
NHS Number:
Date………………………
COMMUNITY NURSING SERVICE (for use in the patient’s home) “Review Daily” Controlled & Other Prescribed Drugs for use in Syringe Drivers / Bolus
Date Time Drug Dose
Administered
Checked
By
Administered
By
Breakthrough Pain
Date Time Drug Dose
Administered
Checked
By
Administered
By
Date………………………
Name:
Date of Birth:
Address:
NHS Number:
SYRINGE DRIVER CHECK CHART HOSPITAL/WARD (IF APPLICABLE) Please complete or Affix Addressograph
EQUIPMENT MODEL
E.G. MCKINLEY T34
D NUMBER: D.O.B:
SURNAME:
EM NUMBER (Separate Form Required Per Driver)
FORENAME:
ADDRESS:
Equipment Within Test Date? YES/NO Equipment out of Test date must not be used and must be reported to Electronics Help Desk – Tel 4286/4197/4792
Is Spare Battery Available? YES/NO
TEL. NO:
HAS THE CORRECT SYRINGE BEEN IDENTIFIED BY THE SYRINGE DRIVER ? YES / NO
Please note if incorrect syringe size / brand displayed - remove the syringe from the driver and ensure that it is reinserted correctly until the correct size and brand is displayed
Date
Time
set up or
checked
(24
HOUR
CLOCK)
Prime New Line
YES/NO
Needle Site
1= Clean
2= Red
3=Inflamed
Connections
Secure
Correct
syringe
identified by
syringe
driver
YES/NO
Infusion rate
setting
(Give reason for
any change to
rate)
Total
volume
infused at
each
check
Volume
left in
syringe
Is the solution
clear
(and not
crystallised)
?
Yes/No
KEY
PAD
LOCK
ON
YES/NO
Battery %
(> 40% for community)
Display Screen
Reading / Pump
Delivering
Is the light
flashing
YES/NO
Name and
signature of
Registered
Nurse
Checked by
Name &
Signature
FREQUENCY OF CHECKS-
IN HOSPITAL:- Checks should be made after 30 minutes of starting the infusion (to see if the driver is working) and then 4 hourly.
IN THE COMMUNITY:- Check on each visit
REFERENCES:-
Infusion Systems- Medical Devices Agency Bulletin, March 2003,
Standards for Infusion Therapy Royal College of Nursing, November 2005
McKinley T34 Syringe Driver Guidelines. Graseby MS26 Syringe Driver Guidelines. North West Wales NHS Trust. c260(a) Policy and Guidelines for Health Care Assistants witnessing the preparation and administration of controlled drugs in a syringe driver in a Community
Hospital
Date
Time
set up or
checked
(24
HOUR
CLOCK)
Prime New Line
YES/NO
Needle Site 1= Clean
2= Red
3=Inflamed
Connections
Secure
Correct
syringe
identified by
syringe
driver
YES/NO
Infusion rate
setting
(Give reason for
any change to
rate)
Total
volume
infused at
each
check
Volume
left in
syringe
Is the solution
clear
(and not
crystallised)
?
Yes/No
KEY
PAD
LOCK
ON
YES/NO
Battery %
(> 40% for community)
Display Screen
Reading / Pump
Delivering
Is the light
flashing
YES/NO
Name and
signature of
Registered
Nurse
Checked by
Name &
Signature
This Form will be used in conjunction with the Medication Chart and Daily Intake & Output Chart A separate form is required for each line Completed forms will be stored in the Nursing Section of the Patients Medical Records